Sphingosine 1-phosphate receptor 2
| GO Term | Evidence Code | Reference |
|---|---|---|
| vasculature development | ||
| vasculature development | ||
| heart morphogenesis | ||
| heart morphogenesis | ||
| embryonic heart tube morphogenesis |
| GO Term | Evidence Code | Reference |
|---|---|---|
| cytoplasm | ||
| plasma membrane | ||
| plasma membrane |
| GO Term | Evidence Code | Reference |
|---|---|---|
| sphingosine-1-phosphate receptor activity | ||
| sphingosine-1-phosphate receptor activity |
| Position | Description | PubMed ID | GlyTouCan ID | Source |
|---|---|---|---|---|
| 24 |
|
|
| Pathway Name | Organism |
|---|---|
| G alpha (i) signalling events | Danio rerio |
| Lysosphingolipid and LPA receptors | Danio rerio |
| DO ID | Disease Name | Source |
|---|---|---|
| DOID:305 | carcinoma |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.5.0
Last updated: April 6, 2026